Mesenchymal Stem Cells Market Anticipates Steady Growth Till 2026

Mesenchymal Stem Cells Market Size, Share,
Trend, Outlook, Future Growth Analysis
And Synthesis 2018 - 2026
Mesenchymal stem cells, also known as Mesenchymal Stromal Cells (MSCs), are adult, fibroblast-like
multipotent cells that can differentiate and mature into tissues of mesodermal origin such as adipocytes,
chondroblasts, and osteoblasts. Mesenchymal stem cells were isolated first time from the bone marrow
and later from various sources such as cord cells, adipose tissue, and molar cells. MSCs in terms of size,
are smaller and are quite difficult to observe in histological sections. A group of mesenchymal stem cells
are called as mesenchyme and is widely distributed in the body. Mesenchymal cells can multiply in
numbers of specialized cells and they can grow in-vitro or in-vivo condition.
Free Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/720
The mesenchymal stem cells play an important role within an organism for suppression of immune cells
activation, increase the number of newer cells, reduce cell death or cell damage in the body, and
secretion of both neurotrophic and angiogenic factors, which are responsible for stabilizing the
extracellular matrix, when transplanted to the brain, this cells promote the reduction of free radical
levels and enhance synaptic connections of damaged neurons, and increases the myelination of axons.
The mesenchymal cells are also able to replace and repair any damaged blood vessel in the cerebrum
brain.
Rise in prevalence of osteoporosis and increase in cancer incidences are expected to support the global
market growth
MSCs have the ability to grow bone tissues through the bone surface to form new bone, which in turn
has the potency to treat osteoporosis. According to the National Institute of Health (NIH), in 2015, the
U.S. accounted for around 53 million people suffering from osteoporosis or at a high risk due to low
bone mass.
According to Osteoporosis Canada, around 1 in 5 men and 1 in 3 women suffer from osteoporotic
fracture during their lifetime, whereas osteoporosis causes around 70-90% of 30,000 hip fractures yearly;
the annual cost to Canada for treating osteoporosis was around US$ 4.0 billion in the year 2012, which
is expected to rise in the upcoming years. Furthermore, according to the International Osteoporosis
Foundation (IOF), annually around 9.0 million people worldwide are suffering from osteoporosis
fractures. The aforementioned factors are expected to bolster the Mesenchymal stem cells market growth
over the forecast period.
Report includes chapters which deeply display the following deliverable about industry :
• Mesenchymal Stem Cells Market Research Objective and Assumption
• Mesenchymal Stem Cells Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Mesenchymal Stem Cells Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Mesenchymal Stem Cells Market, By Regions
• Mesenchymal Stem Cells Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Mesenchymal Stem Cells Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Mesenchymal Stem Cells Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Mesenchymal Stem Cells Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Mesenchymal Stem Cells Market Players
Some of the key market players identified across the value chain of mesenchymal stem cells market are,
Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen,
Cell Applications, PromoCell GmbH, Cyagen Biosciences, Human Longevity Inc., Axol Bioscience, Cytori
Therapeutics, Eutilex Co.Ltd., ID Pharma Co. Ltd., BrainStrom Cell Therapeutics, Cytori Therapeutics
Inc., Neovii Biotech, Angel Biotechnology, California Stem Cell Inc., Stemcelltechnologies Inc., and
Celgene Corporation Inc.
Mesenchymal Stem Cells Market Taxonomy
On the basis of product type, the global Mesenchymal Stem Cells Market is segmented into:
•
Human MSCs
•
Mouse MSCs
•
Rat MSCs
•
Others
On the basis of application, the global Mesenchymal Stem Cells Market is segmented into:
•
Drug discovery and development
•
Injuries
•
Cardiovascular and myocardial infarction
•
Others
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoinginsight/mesenchymal-stem-cells-market-720
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200, Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Rise in prevalence of osteoporosis and increase in cancer incidences are expected to support the global market growth.